A dysfunction in muscle blood vessels could be to blame for the weak muscles and weight loss that most cancer patients ...

A dysfunction in muscle blood vessels could be to blame for the weak muscles and weight loss that most cancer patients ...

Cachexia is a common complication of cancer and is associated with an increased risk of death. The level of growth differentiation factor 15 (GDF-15), a circulating cytokine, is elevated in cancer ...

Here are all the ways medical marijuana helps fight cancer. And as science continues to investigate its benefits, evidence ...

More information: Tomoya Takaoka et al, Prevalence of and Survival with Cachexia among Patients with Cancer: A Systematic Review and Meta-Analysis, Advances in Nutrition (2024). DOI: 10.1016/j ...

When cancer is in the lungs, the simulation reveals patients can die from asphyxiation, where there's not enough oxygen ...

At a cancer center in Alberta, Canada, consecutive patients with cancer (lung or GI; N = 1,473) were assessed at presentation for weight loss history, lumbar skeletal muscle index, and mean muscle ...

“It’s not entirely clear if one can say, ‘I block interleukin-6 and therefore cure cachexia in humans,’” says coauthor Tobias Janowitz, a cancer scientist also at Cold Spring Harbor ...

Patients with cancer cachexia assigned ponsegromab gained significantly more weight than those assigned placebo. Researchers observed improved appetite and higher physical activity in the ...

Preclinical and clinical data demonstrate that neutralizing GDF-15 with visugromab effectively alleviates cancer-induced cachexia, characterized by severe weight and muscle mass loss Patients with ...

The experimental drug ponsegromab is a monoclonal antibody that treats the growth factor that leads to the growth of cancer cells, which is called cachexia, Pfizer said in a news release Saturday.